Literature DB >> 29582240

Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.

Keerthi G S Nair1, Velmurugan Ramaiyan1, Sathesh Kumar Sukumaran2.   

Abstract

The central nervous system, one of the most delicate microenvironments of the body, is protected by the blood-brain barrier regulating its homeostasis. Blood-brain barrier is a highly complex structure that tightly regulates the movement of ions of a limited number of small molecules and of an even more restricted number of macromolecules from the blood to the brain, protecting it from injuries and diseases. However, the blood-brain barrier also significantly precludes the delivery of drugs to the brain, thus, preventing the therapy of a number of neurological disorders. As a consequence, several strategies are currently being sought after to enhance the delivery of drugs across the blood-brain barrier. Within this review a brief description of the structural and physiological features of the barriers and the recently born strategy of brain drug delivery based on the use of nanoparticles are described. Finally, the future technological approaches are described. The strong efforts to allow the translation from preclinical to concrete clinical applications are worth the economic investments.

Entities:  

Keywords:  Blood–brain barrier; Drug delivery; Meningitis; Nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 29582240     DOI: 10.1007/s10787-018-0468-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  44 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

Review 2.  Nanostructures for drug delivery to the brain.

Authors:  L Martin-Banderas; M A Holgado; J L Venero; J Alvarez-Fuentes; M Fernández-Arévalo
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 3.  Therapeutic and diagnostic applications of nanoparticles.

Authors:  Mahmoud Youns; Jörg D Hoheisel; Thomas Efferth
Journal:  Curr Drug Targets       Date:  2011-03-01       Impact factor: 3.465

Review 4.  Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Authors:  R D Broadwell
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes.

Authors:  Eyal Afergan; Hila Epstein; Rachel Dahan; Nickolay Koroukhov; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  J Control Release       Date:  2008-09-04       Impact factor: 9.776

Review 6.  The blood-brain barrier in neuroinflammatory diseases.

Authors:  H E de Vries; J Kuiper; A G de Boer; T J Van Berkel; D D Breimer
Journal:  Pharmacol Rev       Date:  1997-06       Impact factor: 25.468

Review 7.  Nanobiotechnology-based drug delivery in brain targeting.

Authors:  Subas C Dinda; Gurudutta Pattnaik
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

8.  Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport.

Authors:  A K Kumagai; J B Eisenberg; W M Pardridge
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

Review 9.  Clinical implications of HIV-1 drug resistance in the neurological compartment.

Authors:  Andrea Antinori; Antonella Cingolani; Maria Letizia Giancola; Federica Forbici; Andrea De Luca; Carlo Federico Perno
Journal:  Scand J Infect Dis Suppl       Date:  2003

10.  One at a time, live tracking of NGF axonal transport using quantum dots.

Authors:  Bianxiao Cui; Chengbiao Wu; Liang Chen; Alfredo Ramirez; Elaine L Bearer; Wei-Ping Li; William C Mobley; Steven Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-14       Impact factor: 11.205

View more
  7 in total

Review 1.  Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies.

Authors:  Neelam Sharma; Ishrat Zahoor; Monika Sachdeva; Vetriselvan Subramaniyan; Shivkanya Fuloria; Neeraj Kumar Fuloria; Tanveer Naved; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya; Simona Bungau; Tapan Behl; Sukhbir Singh
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-20       Impact factor: 5.190

2.  A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving mice.

Authors:  Tsuneo Nakajima; Shuko Takeda; Yuki Ito; Akane Oyama; Yoichi Takami; Yasushi Takeya; Koichi Yamamoto; Ken Sugimoto; Hideo Shimizu; Munehisa Shimamura; Hiromi Rakugi; Ryuichi Morishita
Journal:  Fluids Barriers CNS       Date:  2022-05-03

Review 3.  Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.

Authors:  Jian Cheng; Jinli Meng; Lei Zhu; Yong Peng
Journal:  Mol Cancer       Date:  2020-03-25       Impact factor: 27.401

Review 4.  Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections.

Authors:  Mahmood Barani; Mahwash Mukhtar; Abbas Rahdar; Ghasem Sargazi; Anna Thysiadou; George Z Kyzas
Journal:  Molecules       Date:  2021-01-02       Impact factor: 4.411

Review 5.  Recent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation.

Authors:  Zhiyuan Ma; Baicheng Li; Jie Peng; Dan Gao
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

Review 6.  Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.

Authors:  Md Mominur Rhaman; Md Rezaul Islam; Shopnil Akash; Mobasharah Mim; Md Noor Alam; Eugenie Nepovimova; Martin Valis; Kamil Kuca; Rohit Sharma
Journal:  Front Cell Dev Biol       Date:  2022-09-02

Review 7.  Non-coding RNAs in Brain Tumors, the Contribution of lncRNAs, circRNAs, and snoRNAs to Cancer Development-Their Diagnostic and Therapeutic Potential.

Authors:  Julia Latowska; Adriana Grabowska; Żaneta Zarębska; Konrad Kuczyński; Bogna Kuczyńska; Katarzyna Rolle
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.